2 news items
Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity
ZOM
9 May 24
amortization, depreciation, non-cash stock compensation, and taxes while reversing out the benefits derived from net interest income.** Non
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
ZOM
1 Apr 24
compensation, and taxes while reversing out the benefits derived from net interest income.** Non-GAAP Adjusted
- Prev
- 1
- Next